TUESDAY, SEPTEMBER 22, 2026 8:38:08 AM
My Quest A/c
Online Trading
Employee Email
(A)+
(A)
(A)-
Skip to main content
Equity
|
Currency
|
Mutual Fund
|
IPO
|
Financial Tools
|
e-Voting
Home
|
About Us
|
Product and Services
Equity
Derivatives
Commodities
Mutual Fund
IPO
Currency
Depository
|
Corporate Consultancy
|
Empowered Investor
|
Download
|
Career
|
Contact Us
Mission
Vision
Board of Directors
Memberships
Why Quest
Commodity
Currency
Equity and Derivatives
Quest News
Equity
Derivatives
Commodities
Mutual Fund
IPO
Currency
Depository
SEARCH
Quotes
News
NAV
Daily Market Tracker
Gainers & Losers
Advances & Declines
Value & Volume Toppers
Live Indices
Index Movers
Buyers & Sellers
Bulk Deals
Block Deals
Sector Watch
Market Analysis
New Highs & Lows
52 Week Highs & Lows
Exchange Holidays
Index Constituents
Unusual Volume
Out & Under Performers
Historical Returns
Stock Screener
Company Profile
Detailed Quotes
Company Background
Board Of Directors
Balance Sheet
Profit & Loss
Quarterly Results
Financial Ratios
Share Price
Price Chart
Beta Analysis
Deliverable Volumes
Technical Chart
Corporate Actions
BSE Announcements
Board Meetings
Book Closure
Bonus Issues
Rights Issues
Delisted Shares
Market Turnover
Change Of Names
Split Of Face Value
Merger & Demerger
Other Markets
ADR Prices
GDR Prices
World Indices
FII Activities
DII Activities
Forex Details
News
Pre-Session
Mid-Session
End-Session
Quick Review
Hot Pursuit
Foreign Markets
Other Markets
Corporate News
Market Beat
Economy News
Currency News
Market Commentary
Mutual Fund News
Commodity News
Corporate Results
Business News
Balance Sheet
Markets > Corporate Information > Balance Sheet
Glenmark Pharmaceuticals Ltd
Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value
(
R
)
NSE
Symbol
Div Yield
%
Market Cap
(
R
s
.Cr)
P/E
(TTM)
EPS
(TTM)
Face Value
(
R
)
532296
INE935A01035
855.7128074
GLENMARK
0.2
69,145.04
47.36
51.73
1
Your Result on : Markets | Equity | Corporate Information | Balance Sheet
Particulars
Mar 2026
(
R
s
.Cr)
Mar 2025
(
R
s
.Cr)
Mar 2024
(
R
s
.Cr)
Mar 2023
(
R
s
.Cr)
Mar 2022
(
R
s
.Cr)
Mar 2021
(
R
s
.Cr)
SOURCES OF FUNDS :
Share Capital
28.22
28.22
28.22
28.22
28.22
28.22
Reserves Total
24122.10
24475.74
22942.40
17849.25
16710.37
14781.29
Equity Share Warrants
0.00
0.00
0.00
0.00
0.00
0.00
Equity Application Money
0.00
0.00
0.00
0.00
0.00
0.00
Total Shareholders Funds
24150.32
24503.96
22970.62
17877.47
16738.59
14809.51
Secured Loans
0.00
298.82
0.00
0.00
0.00
0.00
Unsecured Loans
107.01
530.97
707.29
3221.22
3737.70
3703.99
Total Debt
107.01
829.79
707.29
3221.22
3737.70
3703.99
Other Liabilities
1591.09
132.10
131.94
372.58
121.32
136.61
Total Liabilities
25848.42
25465.85
23809.85
21471.27
20597.61
18650.11
APPLICATION OF FUNDS :
Gross Block
4015.83
3743.15
3392.75
3183.65
3026.28
2848.56
Less : Accumulated Depreciation
1987.93
1763.97
1636.50
1437.70
1273.95
1126.07
Less:Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
2027.90
1979.18
1756.25
1745.95
1752.33
1722.49
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
159.32
154.56
197.67
172.34
109.04
131.40
Producing Properties
0.00
0.00
0.00
0.00
0.00
0.00
Investments
15202.21
15194.91
12964.79
10334.01
8559.39
6989.95
Current Assets, Loans & Advances
Inventories
1288.06
1369.31
1142.69
1090.21
951.66
762.39
Sundry Debtors
3305.59
2550.16
2484.47
2505.66
2678.32
2488.75
Cash and Bank Balance
293.19
132.74
129.15
93.79
29.63
15.79
Loans and Advances
1208.26
725.47
925.17
695.51
743.31
1642.20
Total Current Assets
6095.10
4777.68
4681.48
4385.18
4402.93
4909.12
Less : Current Liabilities and Provisions
Current Liabilities
3270.50
2383.39
3249.79
2952.14
2168.39
1834.31
Provisions
366.26
125.79
354.74
162.52
148.49
133.11
Total Current Liabilities & Provisions
3636.76
2509.18
3604.54
3114.66
2316.88
1967.41
Net Current Assets
2458.34
2268.50
1076.94
1270.52
2086.05
2941.71
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets
968.61
166.59
475.61
1160.25
1137.47
1118.72
Deferred Tax Liability
962.57
224.85
309.77
213.50
214.20
265.43
Net Deferred Tax
6.04
-58.26
165.84
946.75
923.27
853.29
Other Assets
5994.61
5926.97
7648.37
7001.70
7167.54
6011.27
Total Assets
25848.42
25465.86
23809.85
21471.26
20597.62
18650.11
Contingent Liabilities
2590.04
2949.43
2658.49
3443.30
3325.06
3730.17